ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 143 filers reported holding ANI PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $5,000 | -54.5% | 62 | -53.4% | 0.00% | -50.0% |
Q2 2019 | $11,000 | +22.2% | 133 | 0.0% | 0.01% | +14.3% |
Q1 2019 | $9,000 | -18.2% | 133 | -46.4% | 0.01% | -12.5% |
Q4 2018 | $11,000 | 0.0% | 248 | +27.2% | 0.01% | +14.3% |
Q3 2018 | $11,000 | -15.4% | 195 | 0.0% | 0.01% | -30.0% |
Q2 2018 | $13,000 | +225.0% | 195 | +214.5% | 0.01% | +400.0% |
Q1 2018 | $4,000 | 0.0% | 62 | 0.0% | 0.00% | +100.0% |
Q4 2017 | $4,000 | +33.3% | 62 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $3,000 | 0.0% | 62 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $3,000 | 0.0% | 62 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $3,000 | -25.0% | 62 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $4,000 | 0.0% | 62 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $4,000 | -97.1% | 62 | -97.5% | 0.00% | -98.5% |
Q2 2016 | $138,000 | +50.0% | 2,465 | -9.9% | 0.06% | +66.7% |
Q1 2016 | $92,000 | -25.2% | 2,735 | 0.0% | 0.04% | -39.1% |
Q4 2015 | $123,000 | +13.9% | 2,735 | 0.0% | 0.06% | +3.2% |
Q3 2015 | $108,000 | -29.4% | 2,735 | +11.0% | 0.06% | -16.2% |
Q2 2015 | $153,000 | +3725.0% | 2,465 | +3875.8% | 0.07% | +3600.0% |
Q1 2015 | $4,000 | 0.0% | 62 | 0.0% | 0.00% | -33.3% |
Q4 2014 | $4,000 | – | 62 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Capital Management, Inc | 73 | $4,025 | 0.00% |